Although secukinumab has demonstrated high efficacy and favorable safety in moderate‐to‐
severe psoriasis and psoriatic arthritis, patients developing adverse events of special …

The clinical treatment of inflammatory bowel disease (IBD) is challenging. We developed
copper sulfate (CuS)/disulfiram (DSF)/methacrylic acid-ethyl acrylate copolymer (EL) …

The skin is the outermost layer of the body and is exposed to many environmental stimuli,
which cause various inflammatory immune responses in the skin. Among them, fungi are …

BACKGROUND Indications for surgery in inflammatory bowel disease (IBD) include
treatment-refractory disease or severe complications such as obstruction, severe colitis …

5-Aminolevulinic acid (5-ALA) is a naturally occurring nonprotein amino acid licensed as an
optical imaging agent for the treatment of gliomas. In recent years, 5-ALA has been shown to …

Interleukin (IL)-17 and IL-23 inhibitors are both approved for the treatment of moderate-to-
severe plaque psoriasis (PsO), as well as psoriatic arthritis (PsA). In the absence of head-to …

Bovine lactoferricin (LfcinB) has biological properties such as anti-inflammatory and
immunological activity. This study aimed to investigate the protective effects of LfcinB on …

Micro-and nanoplastics (MNPs) are ubiquitous in the environment, resulting in the uptake of
MNPs by a variety of organisms, including humans, leading to particle-cell interaction …

Insecticides are important in agriculture, to reduce human disease, and to decrease the
nuisance of biting insects. Despite this, many have the potential for environmental impacts …

In patients with inflammatory bowel disease (IBD), a combination of dysbiosis, increased
intestinal permeability, and insufficient regulatory responses facilitate the development of …